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ABSTRACT 
 
Aim 
 
The purpose of the research study was to evaluate a diet intervention in relation to 
the perceived weight loss and ways of coping of people living with HIV and 
lipodystrophy.  The objectives were to: 
1. Measure the perceived impact of weight loss upon men with HIV and 
lipodystrophy following a diet intervention; 
2.  Identify strategies used by men to cope with HIV and lipodystrophy following a 
diet intervention; 
Background 
HIV positive people on antiretroviral treatments are normalizing their lives and are 
facing a life long future. Morphological changes occur as a result of antiretroviral 
therapy causing HIV positive people to hesitate commencing treatment. 
Design 
An experimental design incorporating pretests and posttests of experimental and 
control groups was used in the study. 
Methods 
The sample consisted of 30 men over 18 years of age, living with HIV and 
lipodystrophy.  All participants were surveyed by questionnaires and their perceived 
weight loss and ways of coping were measured at baseline and 10 weeks.  
Results 
Findings indicated a significant improvement for perceived weight loss and although 
not significant, all coping processes were used more by the participants in the 
intervention group compared to the control group. 
Conclusions 
   
The diet intervention demonstrated a positive effect particularly upon perceived 
weight loss on men living with HIV and Lipodystrophy in the study setting.  
Relevance to clinical practice 
Diet is a recommended management option for people who endure severe and 
distressing symptoms from antiretroviral therapy. 
 
Key Words: experimental design, HIV/AIDS, nursing care, weight loss, coping, 
nurses. 
 
 
 
 
 
 
   
INTRODUCTION 
 
Antiretroviral therapy is important in the management of people living with HIV as 
it reduces the potential of disease progression and thus the development of an AIDS 
defining illness. A range of side effects come as a consequence of antiretroviral 
therapy, which increases the risks of other disease processes and hence reduce the 
individual’s quality of life. It is important to assist and encourage these people to 
continue taking their medication and at the same time minimise the side effects. 
 
In recent years there have been rapid advancements in the development of 
antiretroviral therapy which have increased the health and survival prospects of 
people living with HIV/AIDS (Williams, 1999). Along with these therapies come 
adverse side effects such as extreme body shape changes for example, lipoatrophy, 
which result in social stigmatisation and clients taking ‘drug holidays’ or abandoning 
their treatment altogether (Shattuck, 2001). The risks associated with this include the 
possibility of disease progression (Katzenstein, 1997). Lipodystrophy is a recognised 
complication of some of the antiretroviral treatments (protease inhibitors and 
nucleoside reverse transcriptase inhibitors) used for HIV therapy (Carr et al. 1999).  
This paper will address the effect of diet on the participants’ perceived weight loss 
and ways of coping. 
 
Lipodystrophy 
 
Lipodystrophy is characterised by changes in the body shape of people who are 
taking a combination of antiretroviral therapy.  The body shape changes are more 
apparent in those who are responding well to treatment, i.e. are healthy and full 
bodied in the first instance, have undetectable viral loads and improved 
CD4+lymphocyte (Kotler, 1998). Antiretroviral treatments are beneficial as they 
lower the viral load (plasma viral ribonucleic acid or RNA) allowing the immune 
system to recover somewhat and reduce the development of opportunistic illnesses 
(Lane, 1999). (Paton et al.  2000) reported that lipodystrophy also occurs in people 
with HIV who are not taking antiretroviral medication, thus making it difficult to 
determine lipodystrophy caused by the course of the disease or by treatment. 
 
   
Lipodystrophy continues to lack a working definition but there is consensus that this 
phenomenon includes: fat accumulation in the breast and/or the dorsocervical region 
and/or the intra-abdominal cavity and/or in discrete lipomas; fat loss (lipoatrophy) 
involving the face and/or the periphery; or both; and veins may be prominent on legs 
and arms. Serum lipid changes also occur and may include; an increase in 
cholesterol, decreased HDL (plasma high-density lipoprotein), increased 
cholesterol/HDL ratio and an increase in triglycerides. Insulin resistance, diabetes 
mellitus and more recently bone metabolic abnormalities have also been associated 
with lipodystrophy (Shattuck, 2001, Martinez et al. 2001, Holstein et al. 2001). 
Other side effects of antiretroviral treatment include diarrhoea, fatigue, headache, 
nausea, mitochondrial toxicity, liver disease and kidney stones. Measurement of 
lipodystrophy is by patient or physician identification (Cofrancesco & Barnett 2000).  
 
As discussed above there are morphological and metabolic changes associated with 
HIV illness, lipodystrophy and antiretroviral therapy.  Epidemiological evidence 
suggests hyperlipidemia and cardiovascular disease are associated with insulin 
resistance. Antiretroviral therapies are also associated with hyperlipidemia, central 
obesity and insulin resistance and, therefore, increase the risk of coronary artery 
disease in people with HIV (Samaras et al. 1999). Abdominal (visceral) obesity is 
also well documented as a predisposing factor in relation to cardiovascular disease 
and insulin resistance is often found in association with abdominal obesity 
(Buemann & Tremblay 1996). 
 
Other physical problems associated with antiretroviral therapy include, 
gastrointestinal effects, fatigue, headache, liver disease and kidney stones (Shattuck 
2001). Wasting in HIV illness is still a problem even with the introduction of 
antiretroviral treatments. Polsky et al. in 2001 argued it might be difficult to 
distinguish between wasting and HIV positive people who present with lipoatrophy. 
They also identified that a decrease in lean mass is associated with wasting but 
increased visceral and dorsocervical fat is related to lipodystrophy.  
 
Mulligan (1999) discussed wasting in HIV positive people as having a negative 
effect upon their survival and quality of life. The current management for wasting 
includes appetite stimulants, cytokine suppressors, protein anabolic agents and 
   
progressive resistance exercise. Shattuck (2001) argued there is an important role for 
nutrition therapy in relation to improved quality of life for HIV positive people and 
the management of antiretroviral therapy. Side effects of these medications including 
the effects of lipodystrophy are reduced.  
 
Dietary Intervention 
 
 Only a few studies have evaluated the effectiveness of a dietary intervention in 
relation to improving weight in HIV positive people and only some of these have 
proven effective in showing a significant change in body weight. Kotler (2000: 582) 
stated, ‘Regardless of the underlying mechanism, weight loss ultimately is a 
consequence of negative caloric balance, so that expenditure must exceed intake (or 
absorption).’ 
 
In past randomised control trials evaluating weight loss and dietary interventions, no 
significant change in weight was found from baseline. This occurred in the study by 
Rabeneck et al. (1998), which compared nutrition counselling with or without oral 
supplementation in a group of HIV positive people who had lost weight. The results 
were similar in the study by Swenk et al. (1999), which examined whether dietary 
counselling increased intake with or without oral supplements in a group of 
malnourished HIV positive people. Melchior et al. (1996) in a controlled, 
randomised, prospective trial were successful in increasing weight by using 
parenteral nutrition compared with dietary counselling in a group of people with 
AIDS. Studies by Kotler et al. (1990) and Kotler et al. (1998) showed no significant 
increase in body cell mass in people with AIDS and malabsorption who received 
parenteral nutrition, but attributed weight gain to an increase in fat mass in these 
people. A prospective study examining the effect of dietary counselling upon dietary 
intake and weight and body composition on HIV positive people by Dowling et a.l 
(1990) found no significant change in body composition even though nutritional 
intake increased. A prospective cohort study by Chlebowski et al. 1995) examined 
the effects of dietary counselling on dietary intake and weight maintenance in a 
group of people with HIV and found weight decreased even though energy intake 
was sufficient. The participants from these studies had HIV but lipodystrophy was 
   
not specified. Quality of life issues and subjective data were not examined in any of 
these studies.  
 
Three studies have investigated the effects of diet upon people with HIV and 
lipodystrophy. Moyle et al. (2001) undertook a randomised open label comparative 
trial comparing diet to diet and pravastatin and reported reduced cholesterol in the 
participants in both groups. Another study by Roubenoff et al. (1999) recommended 
diet as well as exercise should be studied for this population. Nutritional 
interventions have also been recommended as an early intervention for HIV infection 
to manage ongoing nutritional status (Currier et al.  2001). Interestingly, there are 
few studies available to guide nursing practice and antiretroviral-related nutritional 
problems (Keithly & Fields-Gardner 2001). 
 
At present some health services in Australia providing care for HIV positive people 
lack government funded specialist dietician services. Rather, dietician services in 
some of these settings are currently funded through other sources such as donations 
from pharmaceutical companies. 
 
Whilst weight loss has been a clinical manifestation of HIV illness since the 
beginning of the epidemic it is also known to lead to an increased risk of 
opportunistic infections in HIV positive people (Polsky et al. 2001). The Impact of 
Weight Loss Scale has been used previously to assess perceived weight loss and how 
this impacts upon body image, behaviour and affect.  The questionnaire is for use 
with individuals who are prone to involuntary weight loss and measurement is 
reciprocal with greater depression, reduced quality of life, objective nutritional 
deficits and amount of weight loss and was used to measure perceived weight loss in 
the present study (Wagner & Rabkin 1999).  
 
Coping may be defined as ‘cognitive and behavioural efforts to manage specific 
external and/or internal demands appraised as taxing or exceeding the resources of 
the individual’ (Folkman & Lazarus, 1988: 6).  Coping behaviours are an example of 
factors that limit the effects of psychological distress and are described as either 
‘problem focused (changing the source of stress) or emotion focused (regulating 
stressful emotions)’ (Fleishman & Fogel, 1994: 156).  Folkman and Lazarus (1980) 
   
identified that emotion-focussed coping was more likely to be related to health 
problems appraised as uncontrollable and was also related to poorer adjustment to 
illness. Namir et al. (1987) suggested that an active behavioural coping style is 
related to improved emotional adjustment to AIDS.  
 
‘The Ways of Coping Questionnaire is designed to identify the thoughts and actions 
an individual has used to cope with a specific stressful encounter’ (Folkman & 
Lazarus 1988: 5). Mulder et al.(1995) discussed the association of active confrontive 
coping and disease progression and Gifford et al. (1998) discussed the importance of 
teaching people with HIV more effective coping strategies. In the present study, the 
questionnaire identifies changes in coping strategies used by people with HIV and 
lipodystrophy following dietary intervention to manage their HIV illness and the side 
effects of the antiretroviral medication.   
 
Purpose 
 
The purpose of this research study was to evaluate the effects of a diet intervention 
upon the quality of life of people living with HIV and lipodystrophy.  To achieve this 
purpose the following objectives were developed:  
 
1. Measure the perceived impact of weight loss upon men with HIV and 
lipodystrophy following a diet intervention; 
2.  Identify strategies used by men to cope with HIV and lipodystrophy following a 
diet intervention; 
 
 
 
Research questions 
 
To achieve the purpose of this study, the following research questions were 
examined: 
 
1. Is there a difference in perception of weight loss for men living with HIV and 
lipodystrophy following the implementation of a diet program? 
   
 
2. Is there a difference in the coping processes of men living with HIV and 
lipodystrophy following the implementation of a diet program? 
 
Based on the research questions, the following hypotheses were developed.  
• The average scores of perceived weight loss of the participants in the 
diet program over ten weeks will be significantly improved compared to 
the average scores of those who did not participate as measured by the 
Impact of Weight Loss Scale. 
 
• The average scores of the ways of coping of the participants in the diet 
program will be significantly improved over ten weeks compared to the 
average scores of those who did not participate as measured by the Ways 
of Coping Questionnaire. 
 
METHODS 
 
Design 
 
An experimental design incorporating pretests and posttests of experimental and 
control groups was used in the study. 
 
Participants 
 
The population for this study consisted of 30 men living with HIV and lipodystrophy 
who were clients from two medical sites in Brisbane. These two medical sites were 
chosen because the medical staff at these centres managed people with HIV and are 
prescribers of antiretroviral medication. The dietician who attended to the 
participants in the present study also managed clients at these two centres.  
 
 A poster was used at the two centres to assist in recruitment of men who identified 
or believed to be eligible to participate in the project. Clients who expressed verbal 
interest in participating were assessed by the medical or nursing staff on presentation 
for consultation and were given the participant’s information sheet and statement of 
   
consent. To be eligible for this study, the participants had to meet the following entry 
criteria. They had to be male and over 18 years of age; be HIV positive; have a 
diagnosis of lipodystrophy and be presently taking antiretroviral medication at the 
time of this study; not already be participating in a prescribed diet program for the 
past three months; and receive medical approval and consent to participate. 
Measurement of lipodystrophy was by patient and physician identification.  Eligible 
participants who had given written consent were randomly allocated into either the 
intervention or the control group. A computerised random-number generator was 
used to identify the allocation of numbers to the intervention and control groups. The 
names of the participants and the identified numbers were placed in two separate 
boxes. The Administration Officer and the Principal Investigator then pulled names 
and numbers from the boxes and placed them into the allocated groups. 
 
Sample Size 
 
Sample size calculations were based on a significance level of p = 0.05 (two-tailed). 
The sample size was n = 15 per group. For the Impact of Weight Loss Scale which 
ranges from 9 - 36, the suspected range of change was ± 5 for a standard deviation of 
change of about 3. With 15 per group, it was deemed possible to detect differences 
of 3.7 score units or more between control and intervention groups (with 90% power 
and p = 0.05 two tailed). 
 
For a power of 90% at the p = 0.05 (two-tailed) level of significance, with respect to 
the coping style subscales, it was expected to be able to detect the following changes 
(in scale scores) of the following magnitude; confrontive coping 2.57, distancing 
2.19, self-controlling 3.53, seeking social support 2.59, accepting responsibility 1.77, 
escape-avoidance 3.05, planful problem solving 2.89 and positive reappraisal 3.64 
based on standard deviations derived from (Folkman et al. 1986). 
 
Instruments 
 
To investigate the variables of interest, two areas were examined in detail: perceived 
weight loss and ways of coping. To examine perceived weight loss the Impact of 
   
Weight Loss Scale was used. The ways of coping was examined using the Ways of 
Coping Questionnaire.  
 
Impact of Weight Loss Scale 
 
The Impact of Weight Loss Scale is ‘a subjective measure of perceived weight loss 
and related behaviour, body image perception and affect, as well as the scale’s 
relationship to mental health and nutritional measures in an HIV sample’ (Wagner & 
Rabkin 1999:453). There are nine items to this scale. The scale measures perceived 
weight loss and related behaviour, body image perception and affect. Each item is 
rated on a four-point scale of 1-4. The lower end of the scale (in the present study) 1 
(strongly agree) displays increased concerns about ‘weight loss and its impact on 
body image, behaviour and affect’ (Wagner & Rabkin 1999: 454).   The scale score 
is the mean item score. The mean Alpha for the scale in this study is 0.91. This scale 
is used ‘as a screening tool for body image disturbance and associated affect and 
behaviour resulting from weight loss’ (Wagner & Rabkin 1999: 454). Possible total 
scores range from 9–36.  
 
Ways of Coping Questionnaire 
 
The Ways of Coping Questionnaire is a 66 item self report questionnaire which 
identifies coping strategies that people use in the management of internal and 
external demands in specific stressful situations. ‘Coping, when considered as a 
process, is characterized by dynamics and changes that are a function of continuous 
appraisals of the shifting person-environment relationship’ (Folkman et al. 1988: 6) 
 
The questionnaire assesses how people react to stressful events in their lives and 
contains items that describe cognitive and behavioural strategies in the management 
of specific stressful encounters.   There are eight scales to this questionnaire and each 
question is rated on a four point likert scale. At the high end of the scale, scores of 3 
indicate what strategies are used a great deal, at the low end of the scale scores of 0 
reflect does not apply or not used (Folkman & Lazarus 1988).  Possible total scores 
range from 0 to 150. The mean alpha for each item in the present study is: 
Confrontive Coping 0.80, Distancing 0.81, Self-Controlling 0.79, Seeking Social 
   
Support 0.86, Accepting Responsibility 0.80, Escape-Avoidance 0.82, Planful 
Problem Solving 0.77, Positive reappraisal 0.78. The mean alpha for the whole 
instrument was 0.83. 
 
Intervention Programme 
 
Pre and post-tests were conducted to test the diet program. The intervention group 
undertook the diet program, which consisted of four visits to the dietician over a ten 
week period. The initial consultation and assessment was conducted on the first visit, 
followed by follow up visits at two weeks, at six weeks and another visit at ten weeks  
and to provide support to the participants and monitor implementation of the 
program. The intervention group also received an information booklet about diet at 
the commencement of the program, whereas the control group received the diet 
program and information booklet at the end of the study.  There was only one 
dietician involved in delivering the intervention.    
 
The dietician initiated behavioural therapy in this study. Clients learnt self-
management skills that are able to be used in everyday life. The behavioural therapy 
process meets the individual needs of the client. In this study the client’s current 
problems and the reasons they occurred were focussed upon, recorded and assessed 
continually throughout the program. Treatment goals and objectives were also 
specified and recorded. 
 
Motivational interviewing techniques described by Rollnick et al. (1999) were also 
used by the dietician. Each client’s expectations of the costs and benefits of the 
changes they were making and confidence in their ability to achieve their goals were 
measured at each visit by the dietician. The intervention was then developed around 
the issues where an impact was most likely to occur.  
 
 
 
Procedure of Data Collection 
 
   
Prior to commencement, the participants were fully informed about the research 
study verbally, given a written plain language information statement and asked to 
provide written consent. The questionnaires were administered by the same person 
before the program started and again upon completion of the ten week program. 
Ethical approval was obtained from The Prince Charles Hospital Health Service 
District Ethics Committee and Queensland University of Technology Ethics 
Committee. The participants were given information about the study through 
information sheets and written consent was obtained from each participant. 
 
Data analysis 
 
Although the participants in both groups were similar in relation to the demographic 
and health related variables, an Analysis-of-Covariance (ANCOVA) was undertaken 
to examine the hypotheses developed for the study. The ANCOVA design is a 
statistical technique used to control any initial differences in the participants which 
may have been present and which may confound differences between the two groups 
of participants (Tabachnick & Fidell 1996). 
 
A series of one–way between groups ANCOVA’s were performed on Time 2 scores 
of Impact of Weight Loss and Ways of Coping Questionnaire. Time 1 scores of the 
respective dependent variables were used as a covariate to control for Time 1 initial 
differences between the groups. Four other covariates were included: age, number of 
months on antiretroviral therapy, years of education and number of years HIV 
positive.  
 
Range and consistency checks for each item or each questionnaire were conducted 
after data collection.  To minimise potential data entry error, the same person entered 
the data.  
 
Data analysis was undertaken using the Statistical Package for the Social Sciences 
(SPSS version 10, in SPSS Inc., 1999). Computer analysis of frequencies of each 
value of each variable was performed as a check of the accuracy of the data entry. 
The initial process for examining the data aimed to check for errors in coding and 
   
identify important information in the data that may influence the subsequent choice 
of data analysis method.  
 
Based on the design and the purpose of the study, a one-way analysis of variance was 
performed to determine any differences between the two groups in terms of age, 
years of antiretroviral therapy, years of education and years HIV positive. Before the 
statistical analysis was conducted, the assumptions underlying the statistical 
methods, One-way Analysis of Covariance (ANCOVA) were also checked. 
Statistical significance was reported at the conventional p-value of equal to or less 
than 0.05 level (two-tailed). 
 
Descriptive analyses were used to examine demographic variables, the length of time 
participants were taking antiretroviral therapy, the length of time the participants had 
been HIV positive and the number of years of education of the participants. The 
mean and standard deviation for continuous variables were calculated.  
 
RESULTS 
 
Characteristics of participants 
 
The participants were similar in relation to demographic and health related variables, 
which included age, years HIV positive, years of education and months of 
antiretroviral therapy. Any effect these variables had upon the results of the study has 
been controlled for in the analyses undertaken to examine the hypotheses developed 
for the study. 
 
 
Impact of Weight Loss 
 
A one-way between groups ANCOVA was performed to examine if the intervention 
affected Time 2 impact of weight loss scores using Time 1 impact of weight loss 
scores as a covariate. Inspection of means revealed the intervention group reported 
more positive feelings about weight loss than did the control group. A second 
   
ANCOVA was performed to control for the four other possible confounding 
variables: age, months of antiretroviral therapy, years of education and years HIV 
positive, in addition to Time 1 impact of weight loss scores. This did not change the 
scores.  
 
 
 
Ways of  Coping 
 
A one-way between groups ANCOVA was performed to examine if the intervention 
affected Time 2 of the coping subscale scores (confrontive, distancing self-
controlling seeking social support, accepting responsibility, escape avoidance, 
planful problem-solving and positive reappraisal) using Time 1 scores as a covariate. 
A second ANCOVA was performed to control for the four other possible 
confounding variables: age, months of antiretroviral therapy, years of education and 
years HIV positive, in addition to Time 1 coping subscale scores. The scores indicate 
that although not significant the intervention group changed more than did the 
control group. 
 
 
DISCUSSION 
 
 
At the completion of the study 93.3% of participants remained in the intervention 
and the control groups. The participants in both groups (intervention and control) 
were relatively homogenous. The age of the participants ranged between 28 to 65 
years and the greater proportion were single (20) and homosexual (22). This reflects 
national trends with most people with HIV being male and homosexual (National 
Centre in HIV Epidemiology and Clinical Research, 2002). A study by Brown & 
Batterham in 2001 found the majority of people in their study had been HIV positive 
for more than ten years which is a result of antiretroviral therapy improving HIV 
disease outcomes and associated long-term survival. Ethnicity was not included in 
the analysis, as there was only one indigenous person in the participant groups. All of 
the participants at the time of recruitment were able to continue with normal 
activities as measured by the Karnofsky Performance Status scale. Only 5 
participants had previously had an AIDS defining illness and were currently stable. A 
   
study by Keithley et al. in 1992 reported no differences in quality of life scores 
between asymptomatic HIV positive people; those with AIDS related conditions; or 
those with stable AIDS.  
 
Men were chosen for this study as different patterns of morphologic and metabolic 
abnormalities have been shown to occur in males and females with lipodystrophy as 
reported in a study by Muurahainen et al. in 2000. 
 
The Impact of Weight Loss Scale developed by Wagner & Rabkin in 1999, was used 
in this study to identify the relationship with weight loss and its impact on behaviour, 
body image and affect on people living with HIV and lipodystrophy. It was also used 
to identify future treatment needs and as a measure of the effect of current treatment 
on the participants (Wagner & Rabkin 1999). This scale has not been used in any 
previous studies except that by Wagner & Rabkin in 1999. 
 
The participants in the present study presented with fat accumulation, fat loss and a 
combination of both.  Although the sample used in the study by Wagner & Rabkin 
 in 1999 were HIV positive men who had significant weight loss, they did not state 
whether the participants were taking antiretroviral therapy nor whether they had 
lipodystrophy. The intervention group of the present study showed significantly 
improved perception of weight status.  
 
A study by Folkman et al. (1986b) reported that varied coping options maybe used 
according to people’s situational appraisal of control. They found a significant 
relationship between coping and the two major primary appraisal indices, threat to 
self esteem and a threat to a loved one’s wellbeing. Folkman et al (1988) reported 
that if outcomes are identified as changeable then problem focussed coping 
(confrontive coping and planful problem solving) maybe used more, whereas if 
encounters are appraised as having to be accepted, emotion-focussed coping 
strategies (distancing, self controlling, seeking social support, escape avoidance, 
accepting responsibility and positive reappraisal) are more often used.  Although not 
significant the intervention group used confrontive coping more at Time 2 than did 
the control group. 
 
   
A report by Batterham et al. in 2001 suggested that body composition changes 
associated with lipodystrophy have a negative effect upon a person’s self esteem. 
Another study by Siegal et al in 1997 identified that escape avoidance, accepting 
responsibility and self controlling strategies are more associated with negative 
emotions. The participants in the present study identified their own stressful 
encounter in relation to HIV and lipodystrophy at Time 1 and Time 2. Whilst there 
was no significant change observed to any of the scales of the Ways of Coping 
Questionnaire, all coping processes were used more by both the intervention and the 
control groups at Time 2. Confrontive coping, distancing, escape-avoidance and 
seeking social support were used more in both groups particularly the intervention 
group and self controlling was used more by the control group.  In this study both the 
intervention group and the control group used emotion focussed coping processes 
more at Time 2. Folkman et al. (1980) found that emotion-focussed coping was more 
likely to be used for health problems which are not amenable to change. 
 
Some of the symptoms of the HIV illness and the side effects associated with 
antiretroviral therapy (such as lipodystrophy) are not always reversible and this is 
possibly being reflected in the results. A report by Martinez et al. in 2001 also 
indicated that subcutaneous fat loss may not always be reversible and did not change 
for some of the participants in this study. Therefore, a diet intervention may have 
influenced the way the participants in the intervention group appraised and 
reappraised their stressful encounter in relation to lipodystrophy.  
 
The participants in the present study related stressful encounters about HIV and/or 
lipodystrophy to the ways in which they coped. The different results suggest the 
participants used different coping efforts at Time 1 and Time 2 to manage changes in 
the person–environment relationship. This is consistent with the report by Folkman 
et al. (1986b) which identified that both problem focussed and emotion focussed 
coping are used in every stressful encounter. The individual’s thoughts and actions 
change as a result of the appraisal and reappraisal of the shifting person-environment 
relationship.   
 
There have been no other randomised control trials, which have used the Ways of 
Coping Questionnaire in relation to diet and HIV. 
   
 
Limitations 
 
A small sample size compared to the national numbers of people living with HIV and 
lipodystrophy was used in this study so findings only represent populations of similar 
characteristics. A separate study for women would have to be conducted because of 
the differences in presentation of lipodystrophy between the populations.  
 
The instruments used in this study have been proven to have a high reliability and 
validity in previous studies however these studies involved larger populations. It is 
therefore difficult to ascertain whether or not there was an effect for this study. 
 
 Also actual weight was not measured in this study.   
 
.  
CONCLUSION 
 
The results of this study indicated that the diet program was generally found to be 
acceptable and feasible in this study population. The perceived weight loss of the 
participants significantly improved after a ten-week diet intervention compared to the 
control group at the same time. Weight loss in HIV disease and for people with 
lipodystrophy can be severe and distressing and diet is recommended as a 
management option.  
 
The average scores of the ways of coping questionnaire of the intervention group 
were not significantly improved over ten weeks compared to the control group 
although it was shown that the participants in both groups used all types of coping 
processes more at Time 2.  This is because individuals’ thoughts and actions change 
as a result of the shifting person- environment relationship.  
 
Implications for Further practice 
 
The findings showed that perceived weight loss improved in this group of people. 
Perceived weight loss is associated with the side effects of antiretroviral treatment 
   
for HIV as it results in the reluctance of people to commence treatment or people 
stop taking their medication. This places them at risk of disease progression. A 
routine dietary intervention should be offered for all people with HIV who are 
intending to commence antiretroviral treatment. Health professionals including 
nurses in community health centres need to be active in assessing the needs for 
people with HIV who are currently taking or about to commence antiretroviral 
treatments. 
 
A replication of this study is recommended with larger number of participants to 
evaluate whether the changes that occurred are generalisable to the whole of this 
population. 
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Table 1.  Unadjusted and adjusted means and standard deviations (sd) of impact of 
weight loss scale 
Impact of 
Weight Loss 
Unadjusted T1 
 
Unadjusted T2 Adjusted T2 with 
T1 covariate 
Adjusted T2 with 
all covariates 
p 
Intervention 2.72(.70) 3.10(.68) 2.97 2.95 
Control 2.37(.85) 
 
2.38(.75) 2.50 2.53 
0.04 
Note: SD’s not available for adjusted marginal means.  Higher scores represent less problems. 
 
 
 
 
 
 
 
 
 
Table 2. Descriptive statistics: means, standard deviations (sd) 
                                  
Intervention    Control 
    Mean       Mean  t  p 
Age in years 45.79(9.94) 48.21(8.59) 0.69 0.59 
Months of 
Antiretroviral 
Therapy 
51.21(15.29) 47.71(25.99) 0.43 0.11 
Years of Education 13.86(4.24) 12.14(2.91) 1.25 0.08 
Years HIV Positive 10.93(4.21) 9.86(4.07) 0.68 0.94 
 
 
 
 
 
Figure 1  Plot of mean impact of weight loss scores for intervention and control groups  at T1 and T2 (adjusted for all 
covariates)
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Table 3. Unadjusted and adjusted means and standard deviation(sd) of coping 
Confrontive 
Coping 
Unadjusted 
T1 
Unadjusted 
T2 
Adjusted T2 with T1 
Covariate 
Adjusted T2 with 
all covariates 
p 
Intervention 3.79(2.72) 5.57(2.65) 5.75 5.65 
Control 4.71(3.15) 5.57(3.65) 5.39 5.49 
0.90 
Distancing      
Intervention 4.79(3.19) 5.71(3.20) 5.98 6.08 0.97 
Control 5.86(3.21) 6.50(3.94) 6.23 6.13  
Self 
Controlling 
     
Intervention 8.64(4.40)       9.00(4.00) 8.80 9.09 0.56 
Control 7.93 (4.29) 10.14(4.88) 10.34 10.06  
Seeking 
Social 
Support 
     
Intervention 7.00(3.51) 8.50(4.52) 8.51  8.35 0.75 
Control 7.07(4.09) 7.64(4.78) 7.63 7.79  
Accepting 
Responsibility 
     
Intervention 2.79(2.75) 3.00(2.75) 2.92 3.11 0.89 
Control 2.43(2.53) 3.07(2.92) 3.16 2.96  
Escape-
Avoidance 
     
Intervention 4.64(3.56) 6.29(4.60) 6.87 6.76 0.62 
Control 5.79(3.62) 8.07(5.88) 7.49 7.59  
Planful 
Problem 
Solving 
     
Intervention 7.29(3.43) 8.21(4.48) 8.28 8.20 0.91 
Control 7.50(5.42) 8.36(4.65) 8.30 8.38  
Positive 
Reappraisal 
     
Intervention 5.79(3.77) 7.29(5.54) 7.32 7.28 0.88 
Control 5.86(3.51) 7.00(5.57) 7.00 7.01  
Note: SD’s not available for adjusted marginal means.  Higher scores reflects higher use of 
coping. 
 
 
 
 
